Evidence map›Paper›PMID 23114774›Full record

ArticleAntimicrobial agents and chemotherapy2013

Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries.

R Izdebski, A Baraniak, J Fiett, A Adler, M Kazma, J Salomon, C Lawrence, A Rossini, A Salvia, J Vidal Samso and 11 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Detecting Class 1 Integrons and Their Variable Regions inAntibiotics (Basel, Switzerland) · 2024
    Article
  6. High risk of intestinal colonization with ESBL-producing Escherichia coli among soldiers of military contingents in specific geographic regions.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  7. Article
  8. Genomic Analysis of ESBL-ProducingAntibiotics (Basel, Switzerland) · 2022
    Article
  9. Article
  10. High prevalence of blaScientific reports · 2021
    Article
  11. Article
  12. Citrobacter telavivum sp. nov. with chromosomal mcr-9 from hospitalized patients.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  13. Article
  14. High Prevalence of ST131 Subclades C2-Frontiers in cellular and infection microbiology · 2020
    Article
  15. Article
  16. Article
  17. Review
  18. The Transmissibility of Antibiotic-Resistant Enterobacteriaceae in Intensive Care Units.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 6 countries.

R IzdebskiNational Medicines Institute, Warsaw, Poland.
A Baraniak
J Fiett
A Adler
M Kazma
J Salomon
C Lawrence
A Rossini
A Salvia
J Vidal Samso
J Fierro
M Paul
Y Lerman
S Malhotra-Kumar
C Lammens
H Goossens
W Hryniewicz
C Brun-Buisson
Y Carmeli
M Gniadkowski
MOSAR WP2 and WP5 Study Groups
Narodowy Instytut Leków · PLTel Aviv Sourasky Medical Center · ILUniversity of Antwerp · BEInstitut Guttmann · ESIstituti di Ricovero e Cura a Carattere Scientifico · ITHôpitaux Universitaires Paris-Ouest · FRInserm · FRLoewenstein Hospital Rehabilitation Center · ILUniversité Paris-Est Créteil · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prospective project MOSAR was conducted in five rehabilitation units: the Berck Maritime Hôpital (Berck, France), Fondazione Santa Lucia (Rome, Italy), Guttmann Institute (GI; Barcelona, Spain), and Loewenstein Hospital and Tel-Aviv Souraski Medical Center (TA) (Tel-Aviv, Israel). Patients were screened for carriage of Enterobacteriaceae resistant to expanded-spectrum cephalosporins (ESCs) from admission until discharge. The aim of this study was to characterize the clonal structure, extended-spectrum β-lactamases (ESBLs), and acquired AmpC-like cephalosporinases in the Escherichia coli populations collected. A total of 376 isolates were randomly selected. The overall number of sequence types (STs) was 76, including 7 STs that grouped at least 10 isolates from at least three centers each, namely, STs 10, 38, 69, 131, 405, 410, and 648. These clones comprised 65.2% of all isolates, and ST131 alone comprised 41.2%. Of 54 STs observed only in one center, some STs played a locally significant role, like ST156 and ST393 in GI or ST372 and ST398 in TA. Among 16 new STs, five arose from evolution within the ST10 and ST131 clonal complexes. ESBLs and AmpCs accounted for 94.7% and 5.6% of the ESC-hydrolyzing β-lactamases, respectively, being dominated by the CTX-M-like enzymes (79.9%), followed by the SHV (13.5%) and CMY-2 (5.3%) types. CTX-M-15 was the most prevalent β-lactamase overall (40.6%); other ubiquitous enzymes were CTX-M-14 and CMY-2. Almost none of the common clones correlated strictly with one β-lactamase; although 58.7% of ST131 isolates produced CTX-M-15, the clone also expressed nine other enzymes. A number of clone variants with specific pulsed-field gel electrophoresis and ESBL types were spread in some locales, potentially representing newly emerging E. coli epidemic strains.

Indexed as

Bacterial ProteinsBacterial Typing Techniquesbeta-LactamasesClone CellsElectrophoresis, Gel, Pulsed-FieldEscherichia coliEscherichia coli InfectionsEuropeHumansIsraelPhylogenyPhylogeographyAmpC beta-lactamasesBacterial Proteinsbeta-Lactamases

Identifiers

PMID23114774
PMCPMC3535924
OpenAlexW2132355509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.